You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. ADAPT Online: After Deployment Adaptive Parenting Tools

    SBC: IRIS MEDIA INC            Topic: NICHD

    DESCRIPTION (provided by applicant): The goal of this Phase II project, ADAPT Online (After Deployment: Adaptive Parenting Tools), is to strengthen family functioning and improve child outcomes in reintegrating military families. By developing an empirically supported, standalone, web-based parenting intervention for military families with school-aged children, we expect to strengthen parenting pr ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  2. Expediting the Production of High Value, Standardized, and Transparent Data

    SBC: MJ Datacorp, Ltd.            Topic: NCATS

    DESCRIPTION (provided by applicant): Researchers and contractors are under increasing pressure to produce rapid turnaround times for data releases and publications. Inadequate data management is a common threat to good research and impedes the quick release of high value data. Despite its importance, many organizations do not have standardized data management practices that allow them to prepare h ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  3. PDX Pharmaceuticals

    SBC: PDX PHARMACEUTICALS, INC.            Topic: NCI

    Over one million women worldwide are diagnosed with breast cancer each year. Roughly 20% of all breast cancers overexpress the human epidennal growth receptor 2 (HER2-positive subtype). HER2-targeted therapies, including Herceptin and lapatinib, account for 55% of the breast cancer therapy market in 2011 (or 5 billion annually). Response to HER2-targeted therapies typically average about one year ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government